Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2000
08/09/2000EP1024826A1 PASSIVE IMMUNIZATION AGAINST $i(CLOSTRIDIUM DIFFICILE) DISEASE
08/09/2000EP1024825A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity
08/09/2000EP1024824A1 Solid dispersing vaccine composition for oral delivery
08/09/2000EP1024823A1 Prevention and treatment of adhesion formation
08/09/2000EP1024814A2 Use of antifungal agents for the topical treatment of fungus-induced mucositis
08/09/2000EP1024806A1 Use of non-immunosuppressive compounds for promoting nerve regeneration
08/09/2000EP0786083B1 Diagnosis and monitoring process, and medicaments for the therapy of states of shock in human beings
08/09/2000EP0759780B1 Improved modified live brsv vaccine
08/09/2000EP0690914B1 Allergenic protein and peptides from house dust mite and uses therefor
08/09/2000EP0640133B1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
08/09/2000EP0629238B1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
08/09/2000EP0568645B1 Mixed specificity fusion proteins
08/09/2000EP0533846B1 The ciliary neurotrophic factor receptor
08/09/2000CN1262690A Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of same
08/09/2000CN1262626A Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant
08/09/2000CN1262129A Pig erysipelothrix rhusiopathiae antigen and vaccine composition thereof
08/09/2000CN1055249C Analgesia medicine and its mfg. method
08/08/2000US6100446 Plant cell transformed with nucleotide sequences which code a degratory enzymatic protein; for pollution control
08/08/2000US6100390 Nucleotide sequences coding nematode protein; for the prevention of nematode infection of animals
08/08/2000US6100388 Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
08/08/2000US6100387 Chimeric polypeptides containing chemokine domains
08/08/2000US6100380 Amino acid sequences; for the treatment of infections, anemias, allergies and immune defects
08/08/2000US6100298 Mixture of drug and n-(4-(carboxypropyl)phenyl-4-phenyl-butyramide for improved oral drug delivery
08/08/2000US6100241 Nucleic acids encoding an immunogenic fragment of eimeria lactate dehydrogenase (ldh) which will react with antiserum raised against the ldh; preparing a vector vaccine against coccidiosis; administering to prevent coccidiosis in birds
08/08/2000US6100234 Treatment of HIV
08/08/2000US6100088 Viral vaccines
08/08/2000US6100071 Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
08/08/2000US6100069 Amino acid sequence of peptidyl-propyl cis/trans isomerase involved in protein folding; for screening bacteriostats, bactericides, and antibiotics; diagnosis and prophylaxis
08/08/2000US6100067 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum at the sporozoite stage and in the hepatocytes
08/08/2000US6100066 Nucleotide sequence encoding an immunogenic lipoprotein b polypeptide; for vaccines used in prevention and treatment of infections
08/08/2000US6100065 Recombinant polypeptide particles with high immunogenicity; comprises portion of pre-s1 peptide and surface antigen peptide
08/08/2000US6100064 Increasing secretion by culturing cells transformed with recombinant vector encoding cytomegalovirus gb protein that may have deactivated protease site and lacks transmembrane encoding domain but has cytoplasmic domain
08/08/2000US6100062 Expression system for HSCLOCK
08/08/2000US6100060 Recombinant expression system of polynucleotide encoding a specific amino acid sequence and present in a host cell; for recombinant production of wnt-5b polypeptides important in developmental signal transduction
08/08/2000US6100059 Compounds
08/08/2000US6099853 Vaccine containing deactivated bacteria
08/08/2000US6099848 Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use
08/08/2000US6099847 Genetic eengineering
08/08/2000US6099846 Immunocomplex; forming antibodies
08/08/2000US6099843 Used to protect animals from diseases caused by parasitic helminths
08/08/2000US6099842 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin
08/08/2000US6099841 Include hgf receptor antibodies and fragments thereof; used to treat a pathological liver condition
08/08/2000US6099840 Variant hbsag protein of fragment thereof displaying the antigenicity of hepatitis b virus surface antigen
08/08/2000US6099839 Gonococcal anti-idiotypic antibodies and methods compositions using them
08/08/2000US6099838 For the prevention or reversal of transplant rejection as well as therapy for autoimmune diseases
08/08/2000US6099823 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/08/2000CA2233144C Arf-p19, a novel regulator of the mammalian cell cycle
08/08/2000CA2219795C Modulation of cholesteryl ester transfer protein (cetp) activity
08/08/2000CA2014318C Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
08/08/2000CA2002218C Neoglycoproteins, the preparation and use thereof
08/08/2000CA1341082C Method of treating tumor cells by inhibiting growth factor receptor function
08/08/2000CA1341074C Hbv surface antigen particles, prepared by recombinant dna processes, composed of different epitopes, selected from the pre-s and s-peptides as a new vaccine
08/03/2000WO2000044913A1 Metalloprotease polynucleotides and polypeptides
08/03/2000WO2000044905A1 Slow growing acid-fast bacterium polypeptide
08/03/2000WO2000044904A1 Basb059 polypeptides from neisseria meningitidis
08/03/2000WO2000044899A1 Her-2/neu fusion proteins
08/03/2000WO2000044887A1 Peptides and proteins for desensitizing subjects allergic to bee venom and compositions containing same
08/03/2000WO2000044884A1 Bhv-1 gene-deleted virus vaccine
08/03/2000WO2000044880A1 Means for inducing or increasing the immunogenicity of myeloid acute leukemia cells
08/03/2000WO2000044878A1 Compartmentalization of recombinant polypeptides in host cells
08/03/2000WO2000044790A1 Anti-ccr1 antibodies and methods of use therefor
08/03/2000WO2000044788A1 Production of tetravalent antibodies
08/03/2000WO2000044781A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
08/03/2000WO2000044779A1 MurA
08/03/2000WO2000044777A1 Antibodies specific to kdr and uses thereof
08/03/2000WO2000044773A1 STAPHYLOCOCCUS AUREUS fabG
08/03/2000WO2000044758A1 Immunological adjuvant compound
08/03/2000WO2000044438A1 Delivery of macromolecules into cells
08/03/2000WO2000044410A2 Composition and method for obtaining specific immunisation against one or more antigens using different recombinant vectors
08/03/2000WO2000044406A2 Dna vaccines against hantavirus infections
08/03/2000WO2000044405A1 Dmsa promoters and derivatives thereof used for controlled expression of foreign genes
08/03/2000WO2000044404A2 Methods for inhibiting brain tumor growth by using selected integrin antagonists
08/03/2000WO2000044403A1 Her-2 binding antagonists
08/03/2000WO2000044402A1 Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
08/03/2000WO2000044395A1 Methods and compositions for modulating fertility
08/03/2000WO2000044392A2 Identification of specific differentially expressed mycobacterial antigens
08/03/2000WO2000044389A2 Method for preparing membrane vesicles
08/03/2000WO2000044365A1 Methods for preventing graft rejection and ischemia-reperfusion injury
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000044349A1 Non-invasive vaccination through the skin
08/03/2000WO2000044225A1 TREATING CANCERS ASSOCIATED WITH OVEREXPRESSION OF HER-2/neu
08/03/2000WO2000027874A3 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
08/03/2000WO2000026238A3 Biological materials and methods useful in the diagnosis and treatment of prion diseases
08/03/2000WO2000024896A3 Biological material for preparing pharmaceutical compositions for treating mammals
08/03/2000WO2000023105A3 Adjuvant systems and vaccines
08/03/2000WO2000020609A3 Protective recombinant haemophilus influenzae high molecular weight proteins
08/03/2000WO2000014240A3 Attenuated salmonella sp12 mutants as antigen carriers
08/03/2000WO2000009691A9 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
08/03/2000WO2000008174A9 β-CASEIN EXPRESSING CONSTRUCTS
08/03/2000WO2000008051A3 Immunological herpes simplex virus antigens and methods for use thereof
08/03/2000WO2000001823A3 Flt3-l mutants and methods of use
08/03/2000WO2000000617A9 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons
08/03/2000WO1999063975A3 A method for stimulating the immune system
08/03/2000WO1999062941A8 Serpentine transmembrane antigens expressed in human cancers and uses thereof
08/03/2000DE19903345A1 Kompartimentierung von rekombinanten Polypeptiden in Wirtszellen Compartmentalization of recombinant polypeptides in host cells
08/03/2000CA2368214A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
08/03/2000CA2363565A1 Basb059 polypeptides from neisseria meningitidis
08/03/2000CA2361553A1 Antibodies specific to kdr and uses thereof
08/03/2000CA2361353A1 Product and method for obtaining specific immunisation with one or more antigens
08/03/2000CA2361271A1 Methods and compositions for modulating fertility
1 ... 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 ... 1823